Eli Lilly and Company News - August 5, 2026
🟢 Eli Lilly is trading 7.29% up today on a major revenue guidance hike and GLP-1 strength
Eli Lilly is trading 7.29% up at $1,213.51 following its August 5 earnings report, driven by a significant increase in full-year revenue guidance and continued...
Eli Lilly's second quarter revenue surged 48% to $23.0B, prompting a raised FY26 outlook.
Eli Lilly reported second quarter 2026 revenue of $23.0 billion, up 48% year-over-year, and reported EPS of $7.94. The results were driven by strong demand for...
🟢 Eli Lilly surges 5.3% in pre-market on strong Q2 earnings beat and raised full-year guidance
• Eli Lilly is trading 5.3% up at $1,175.00 in pre-market after reporting second-quarter 2026 financial results that exceeded analyst expectations. • The...